Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance

John O'Reilly, Melvyn M Jones, Jill Parnham, Kate Lovibond, Michael Rudolf, Guideline Development Group, Phyo Kyaw Myint

Research output: Contribution to journalArticlepeer-review

56 Citations (Scopus)

Abstract

Over three million people in the United Kingdom are estimated to have chronic obstructive pulmonary disease (COPD), of whom more than two million remain undiagnosed, representing the so called “missing millions” alluded to in the draft national strategy for COPD.1 2 3 This article summarises the most recent recommendations from the National Institute for Health and Clinical Excellence (NICE) on the management of stable chronic obstructive pulmonary disease in primary and secondary care,4 which update the COPD guidelines first published by NICE in 2004.5 The summary contains the most important recommendations relating to new diagnostic criteria for COPD, changes to the classification of severity of airflow obstruction, the need for multidimensional severity assessment, a new algorithm for inhaled drug treatments (figure⇓), and the value of early pulmonary rehabilitation.
Original languageEnglish
Article numberc3134
JournalBritish Medical Journal (Clinical Research Ed.)
Volume340
DOIs
Publication statusPublished - 25 Jun 2010

Keywords

  • bronchodilator agents
  • dyspnea
  • forced expiratory volume
  • humans
  • practice guidelines as topic
  • pulmonary disease, chronic obstructive
  • respiratory therapy
  • smoking cessation
  • vital capacity

Fingerprint Dive into the research topics of 'Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance'. Together they form a unique fingerprint.

Cite this